Published in Hepatitis Weekly, September 25th, 2006
These combination data demonstrate antiviral effects of HCV-796 across multiple genotypes of hepatitis C virus, in treatment-naive adult subjects with chronic hepatitis C infection. Across all dose groups, the combination of HCV-796 and pegylated interferon produced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly